Western Blotting Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.50 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Western Blotting Market Analysis
The western blotting market is expected to register a CAGR of 6.5% over the forecast period (2022-2027).
COVID-19 had a significant impact on the western blotting market due to the unexpected spread. For instance, as per the article published in 2020 under the title 'COVID-19: Is there a role for Western blots and skin testing for determining immunity and development of a vaccine?', for diagnostic purposes and to assess immunity, combining serologic testing, that includes Western blots, along with skin testing using SARS-CoV-2 antigens for measuring DTH reactions, was likely to be beneficial. When examining the humoral immune response in patients recovering from COVID-19, the Western blot technique was anticipated to be helpful for locating immunogenic antigens that were likely to be utilized for vaccine development. Hence, as per the factors mentioned above, COVID-19 had a notable impact on the western blotting market.
The western blotting market is majorly driven by factors such as the rising burden of chronic diseases across the globe, growing research activities in the biotech and pharma sector, and raised R&D investment done by pharmaceutical and biotechnology companies. For instance, as per the 2022 update from the Centers for Disease Control and Prevention (CDC), six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in America, and they are also a leading driver of health care costs.
Western blotting is a widely known and used test that is used in cell and molecular biology. With the help of this test, one can detect the specific type of protein from the complex mixture of proteins that are extracted from the cell. This test has gained attraction in the market due to its specificity, low cost, and ease of use.
Despite the technique that has evolved since its inception, there have been several advancements in this technique that occurred in the last decade. For instance, as per the article published in 2021 under the title 'Emerging techniques of western blotting for purification and analysis of protein', the arrival of western blotting kits (Pierce Fast of Thermo Scientific) and simplified processes (Western Workflow of Bio-Rad's V3) were open to creating western blotting quicker and more quantifiable. In the past 5-year progress was made in the prepping of gel, imagers of fluorescence, chemiluminescence, and fluorescent antibodies as companies expended a large sum each year on the Western Blotting methodology. Micro fluidical systems significantly lower the duration of time and number of reagents and antibodies needed for western blotting. Those technologies were also allowed to adjust to high-performance systems. Hence, owing to the certain characteristics of the western blot test, the market is believed to witness considerable growth over the forecast period.
As a result of the factors mentioned, the studied market is anticipated to grow throughout the analysis period. However, the alternatives for western blot and accuracy issues restrain the market growth.
Western Blotting Market Trends
This section covers the major market trends shaping the Western Blotting Market according to our research experts:
Disease Diagnostic Segment is Likely to be Witnessing a Healthy CAGR Over the Forecast Period
Western blot test is having a wide range of applications in medical diagnostics. For the diagnosis of diseases such as BSE (Bovine Spongiform Encephalopathy), FIV (Feline Immunodeficiency Virus), HBV (Hepatitis B Virus) infection, and Lyme Disease among others. Generally, this test is used as a confirmatory test for the above-mentioned diseases after the ELISA test is done with a positive result. For Lyme Disease, the United States Food and Drug Administration has suggested the two-tier protocol using an ELISA test initially and then the specific western blot tests for the confirmation of diagnosis if the results of ELISA are positive. Previously, western blotting was commonly done to confirm the HIV diagnosis.
The increasing prevalence of HIV, Lyme disease, and hepatitis are major fueling factors for the market growth. For instance, as per the 2021 update from Global HIV & AIDS statistics, 38.4 million people globally were living with HIV in 2021. Moreover, 1.5 million people became newly infected with HIV in 2021. A higher prevalence of such diseases causes more diagnostic tests and thus boosts market growth. Furthermore, as per the article published in 2020 under the title 'A Practical Approach to the Diagnosis of Lyme Borreliosis: From Clinical Heterogeneity to Laboratory Methods', the diagnosis of Lyme Borreliosis was presently predicated on a two-tier serology at all phases of the infection, except when erythema migrans was present, according to European and North American recommendations. The first test in the two-tier testing process was an ELISA, EIA, or VlsE/C6 test, and the second test was a Western blot/Immunoblot assay. Hence the increase in the utilization of western blotting in the diagnostic testing of diseases like Lyme disease, and HIV boosts the market growth.
Hence, owing to the significance of this test in the disease diagnosis, it is indicated that this segment is anticipated to be witnessing a healthy CAGR over the forecast period.
North America is Expected to Dominates the Western Blotting Market Over the Forecast Period
The increasing prevalence of chronic diseases and the increasing R&D investment by the pharma and biotech companies are expected to drive the growth of the studied market in North America. According to the 2022 update from CDC, six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in America. To reduce the risk and improve the quality of life, people tend to diagnose the chronic disease at the earliest and for that purpose, western blotting is likely to be used widely thereby boosting the market growth. Furthermore, in America, health care costs are up to USD 4.1 Trillion annually. Moreover, the Lyme disease-affected areas in the United States are found to be high. For instance, as per the report from 'Lyme Disease: A Continuing Concern - A FAIR Health Infographic', in 2021 Lyme disease was more found in New Jersey, Vermont, Rhode Island, Connecticut, and Maine.
Furthermore, product launches, company collaborations, and initiatives are boosting the market growth in the studied region over the forecast period. For instance, in January 2021, Bio-Rad Laboratories, a global leader in life science research and clinical diagnostic products, announced the launch of the Bio-Rad Western Blotting Learning Center, an online library that provides comprehensive resources, information, and guidance to help researchers improve their experimental western blotting (or immunoblotting) approaches to obtain high-quality data.
Hence as per the factors mentioned above, the analyzed market is predicted to grow in the North American region over the forecast period.
Western Blotting Industry Overview
The major players are having competition among themselves for the market share and with the rising application of this test and growing pharmaceutical and biotechnology industries, it is believed that few small to mid-sized companies will penetrate the market soon and hold a substantial share in the market. The major market players operating in the western blotting market include Danaher Corporation (Cytiva), Thermofisher Scientific, Biorad laboratories, Perklin Elmer, and Merck & Co. among others.
Western Blotting Market Leaders
-
Thermo Fisher Scientific, Inc.
-
Bio-Rad Laboratories, Inc.
-
PerkinElmer, Inc.
-
Merck & Co., Inc.,
-
Danaher Corporation (Cytiva)
*Disclaimer: Major Players sorted in no particular order
Western Blotting Market News
- In April 2022, Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its AvivaBlot product line of ECL reagents for western blot application. This new portfolio supports picogram to low femtogram detection of proteins via enhanced and stabilized chemiluminescent detection.
- In January 2022, Bio-Techne Corporation announced that ProteinSimple, a Bio-Techne brand, released its Stellar NIR / IR Detection Modules for Jess automated western blotting system. Stellar fluorescence modules enable the detection of low abundance proteins while multiplexing multiple analytes within the same detection lane, setting a new industry standard for western blotting fluorescence detection sensitivity. Multi-color immunoassays can also be run alongside total protein staining using Stellar detection modules.
Western Blotting Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Proteomics Market Across the Globe
4.2.2 Increasing R&D Investment by the Pharma and Biotech Companies
4.2.3 Wide Applications of the Western Blot Test
4.3 Market Restraints
4.3.1 Availability of the Alternatives for Western Blot
4.3.2 Accuracy Issues
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
5.1 By Product
5.1.1 Instruments
5.1.1.1 Gel Electrophoresis Instruments
5.1.1.2 Blotting Systems
5.1.1.3 Imagers
5.1.1.3.1 Chemiluminescent Imagers
5.1.1.3.2 Fluorescent Imagers
5.1.1.3.3 Others
5.1.2 Consumables
5.1.2.1 Reagents
5.1.2.2 Kits
5.2 By Application
5.2.1 Biomedical & Biochemical Research
5.2.2 Disease Diagnostics
5.2.3 Others
5.3 By End-User
5.3.1 Academia and Research Institutes
5.3.2 Diagnostic Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories, Inc.
6.1.2 Thermo Fisher Scientific, Inc.
6.1.3 LI-COR Biosciences
6.1.4 Bio-Techne Corporation
6.1.5 Merck & Co., Inc.
6.1.6 PerkinElmer, Inc.
6.1.7 Cell Signaling Technology
6.1.8 Advansta, Inc.
6.1.9 Danaher Corporation (Cytiva)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Western Blotting Industry Segmentation
As per the scope of the report, the western blot is an analytical technique that is used in molecular biology, immunogenetics, and other disciplines of diagnostics for the identification of specific proteins from the sample of tissue homogenate or extract. The Western Blotting Market is segmented by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics, Others) End Users (Academia and Research Institutes, Diagnostic Centers, Others), and Geography (North America, Europe, Asia-Pacific, South America, Middle East, and Africa). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product | |||||||||
| |||||||||
|
| By Application | |
| Biomedical & Biochemical Research | |
| Disease Diagnostics | |
| Others |
| By End-User | |
| Academia and Research Institutes | |
| Diagnostic Centers | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Western Blotting Market Research FAQs
What is the current Global Western Blotting Market size?
The Global Western Blotting Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)
Who are the key players in Global Western Blotting Market?
Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Merck & Co., Inc., and Danaher Corporation (Cytiva) are the major companies operating in the Global Western Blotting Market.
Which is the fastest growing region in Global Western Blotting Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Western Blotting Market?
In 2024, the North America accounts for the largest market share in Global Western Blotting Market.
What years does this Global Western Blotting Market cover?
The report covers the Global Western Blotting Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Western Blotting Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Western Blotting Industry Report
Statistics for the 2024 Western Blotting market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Western Blotting analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
